Olaparib
(UPDATE) Niraparib
Mirvetuximab Soravtasine-gynx (Elahere)
Trametinib
Bevacizumab
CancerCare
Rivkin Center for Ovarian Cancer
NCCN Guidelines for Patients®
National Ovarian Cancer Coalition